Finance

Lists
Why is BLISSGVS down 4,90%?
Dive Deeper
BLISSGVS:NSE
Bliss GVS Pharma Ltd
620,05 INR
-4,90%
(-31,95) 1D
19 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for BLISSGVS...
Open
662,50 INR
High
662,50 INR
Low
620,00 INR
Mkt. cap
65,96 მლრდ.
Avg. vol.
321,42 ათ.
Volume
118,22 ათ.
Dividend
0,24%
Quarterly dividend
0,38 INR
Ex-dividend date
8 ივლ. 2026
P/E ratio
49,18
52-wk high
739,90 INR
52-wk low
118,00 INR
EPS
12,61 INR
Shares outstanding
103,15 მლნ.
No. of employees
1 ათ.
Open
662,50 INR
High
662,50 INR
Low
620,00 INR
Mkt. cap
65,96 მლრდ.
Avg. vol.
321,42 ათ.
Volume
118,22 ათ.
Dividend
0,24%
Quarterly dividend
0,38 INR
Ex-dividend date
8 ივლ. 2026
P/E ratio
49,18
52-wk high
739,90 INR
52-wk low
118,00 INR
EPS
12,61 INR
Shares outstanding
103,15 მლნ.
No. of employees
1 ათ.
News stories
From web sources and news partners
About Bliss GVS Pharma Ltd
CEO-
Employees1,03 ათ.
Founded1984
Headquarters-
SectorPharmaceutical industry
Last report
12 აგვ. 2026
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
2,86 მლრდ. / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
2,44 მლრდ.
2,18 მლრდ.
2,57 მლრდ.
2,86 მლრდ.
Cost of goods sold
1,18 მლრდ.
1,02 მლრდ.
1,36 მლრდ.
1,14 მლრდ.
Cost of revenue
1,18 მლრდ.
1,02 მლრდ.
1,36 მლრდ.
1,14 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
333,51 მლნ.
359,36 მლნ.
1,00 მლრდ.
430,47 მლნ.
Operating expense
1,03 მლრდ.
901,49 მლნ.
844,80 მლნ.
1,05 მლრდ.
Total operating expenses
2,21 მლრდ.
1,92 მლრდ.
2,21 მლრდ.
2,19 მლრდ.
Operating income
234,96 მლნ.
264,40 მლნ.
363,12 მლნ.
664,63 მლნ.
Other non operating income
201,78 მლნ.
184,56 მლნ.
-597,23 მლნ.
96,00 მლნ.
EBT including unusual items
406,33 მლნ.
408,96 მლნ.
449,50 მლნ.
754,83 მლნ.
EBT excluding unusual items
406,33 მლნ.
434,09 მლნ.
431,08 მლნ.
754,83 მლნ.
Income tax expense
120,44 მლნ.
161,17 მლნ.
79,51 მლნ.
241,11 მლნ.
Effective tax rate
29,64%
39,41%
17,69%
31,94%
Other operating expenses
612,37 მლნ.
458,64 მლნ.
-244,91 მლნ.
516,84 მლნ.
Net income
272,50 მლნ.
232,66 მლნ.
355,75 მლნ.
500,97 მლნ.
Net profit margin
11,15%
10,66%
13,84%
17,54%
Earnings per share
-
-
-
-
Interest and investment income
-
-
167,47 მლნ.
-
Interest expense
-30,42 მლნ.
-14,86 მლნ.
-20,08 მლნ.
-5,79 მლნ.
Net interest expenses
-30,42 მლნ.
-14,86 მლნ.
147,40 მლნ.
-5,79 მლნ.
Depreciation and amortization charges
82,62 მლნ.
83,50 მლნ.
86,71 მლნ.
99,38 მლნ.
EBITDA
317,28 მლნ.
326,86 მლნ.
431,12 მლნ.
732,63 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები